Ibn Alhaytham Hospital (AMM:IBNH) ROCE %: 0.55% (As of Mar. 2026)


AMM:IBNH Ibn Alhaytham Hospital AMM:IBNH
33 GF Score
Price JOD0.86
GF Value JOD0.83
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Ibn Alhaytham Hospital ROCE %?

Ibn Alhaytham Hospital AMM:IBNH 33 ROCE % is 0.55% as of Mar. 2026. GuruFocus rates AMM:IBNH with a GF Score™ of 33/100 and a GF Value™ of JOD0.83 (Fairly Valued). The stock has 9 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ibn Alhaytham Hospital's annualized ROCE % for the quarter that ended in Mar. 2026 was 0.55%.

Ibn Alhaytham Hospital  (AMM:IBNH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ibn Alhaytham Hospital ROCE % Related Terms

Ibn Alhaytham Hospital ROCE % Historical Data

* Premium members only.

The historical data trend for Ibn Alhaytham Hospital's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ibn Alhaytham Hospital ROCE % Chart

Ibn Alhaytham Hospital Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.07 -12.04 -11.86 7.22 9.08

Ibn Alhaytham Hospital Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.19 10.86 9.69 8.84 0.55
AMM:IBNH
33GF Score
Ibn Alhaytham Hospital AMM:IBNH
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ibn Alhaytham Hospital ROCE % Calculation

Ibn Alhaytham Hospital's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=1.195/( ( (27.605 - 15.152) + (30.582 - 16.699) )/ 2 )
=1.195/( (12.453+13.883)/ 2 )
=1.195/13.168
=9.08 %

Ibn Alhaytham Hospital's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=0.076/( ( (30.582 - 16.699) + (31.487 - 17.826) )/ 2 )
=0.076/( ( 13.883 + 13.661 )/ 2 )
=0.076/13.772
=0.55 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.55% mean?
Ibn Alhaytham Hospital (AMM:IBNH) has a ROCE % of 0.55% as of Mar. 2026.
Is Ibn Alhaytham Hospital's ROCE % too high?
Ibn Alhaytham Hospital's current ROCE % is 0.55%. The Healthcare Providers & Services industry median ROCE % is 6.41. Ibn Alhaytham Hospital's value of 0.55% is 91.4% below this industry median. Overall, Ibn Alhaytham Hospital has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ibn Alhaytham Hospital's ROCE % compare to HCA and THC?
Ibn Alhaytham Hospital's ROCE % of 0.55% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Ibn Alhaytham Hospital's value of 0.55% is 91.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ibn Alhaytham Hospital's current ROCE % of 0.55% is 91.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ibn Alhaytham Hospital's current ROCE % is 0.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibn Alhaytham Hospital stock overvalued right now?
Based on GuruFocus' analysis, Ibn Alhaytham Hospital (AMM:IBNH) is currently considered Fairly Valued. The stock's GF Value™ is JOD0.83, compared to a current price of JOD0.86 — trading 3.6% above its estimated fair value. The current ROCE % is 0.55% and 91.4% below the Healthcare Providers & Services industry median of 6.41. Ibn Alhaytham Hospital's overall GF Score™ is 33/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Ibn Alhaytham Hospital (AMM:IBNH), the current ROCE % is 0.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ibn Alhaytham Hospital (AMM:IBNH) Overvalued in 2026?

Based on GuruFocus' analysis, Ibn Alhaytham Hospital stock appears to be overvalued. The current stock price of JOD0.86 is trading 3.6% above its estimated GF Value™ of JOD0.83. GuruFocus considers Ibn Alhaytham Hospital to be Fairly Valued.

Key valuation signals for AMM:IBNH:

  • ROCE %: 0.55%
  • GF Value™: JOD0.83 vs. price of JOD0.86 (3.6% above fair value)
  • GF Score™: 33/100 with 9 warning signs
  • Industry Position: 91.4% below the Healthcare Providers & Services median

No single metric tells the full story. See the AMM:IBNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ibn Alhaytham Hospital Business Description

Address Al-Madina Al-Monawara Street, Amman, JOR, 11194
Ibn Alhaytham Hospital operates as a hospital in Jordan. The Company's main objectives is to found and establish a hospital for general casses And especially ophthalmology, Otorhinolaryngology, Medicine and Neurosurgery and to Import a necessary medical equipment and supplies. The company operates in segments, which comprise of Medical & investments and others.
33GF Score

Get the complete analysis for AMM:IBNH

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD0.86
Price
JOD0.83
GF Value